Lbmc Investment Advisors LLC Has $379,000 Stake in Align Technology, Inc. $ALGN

Lbmc Investment Advisors LLC trimmed its position in Align Technology, Inc. (NASDAQ:ALGN) by 20.0% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,000 shares of the medical equipment provider’s stock after selling 500 shares during the quarter. Lbmc Investment Advisors LLC’s holdings in Align Technology were worth $379,000 at the end of the most recent reporting period.

Several other hedge funds have also recently bought and sold shares of ALGN. Teacher Retirement System of Texas acquired a new position in Align Technology during the first quarter worth $1,647,000. Asset Management One Co. Ltd. raised its stake in Align Technology by 14.5% during the first quarter. Asset Management One Co. Ltd. now owns 31,624 shares of the medical equipment provider’s stock worth $5,024,000 after acquiring an additional 4,009 shares in the last quarter. American Assets Inc. acquired a new position in Align Technology during the fourth quarter worth $417,000. Janney Montgomery Scott LLC raised its stake in Align Technology by 48.9% during the first quarter. Janney Montgomery Scott LLC now owns 10,120 shares of the medical equipment provider’s stock worth $1,608,000 after acquiring an additional 3,325 shares in the last quarter. Finally, Wealth Enhancement Advisory Services LLC raised its stake in Align Technology by 44.3% during the first quarter. Wealth Enhancement Advisory Services LLC now owns 9,380 shares of the medical equipment provider’s stock worth $1,490,000 after acquiring an additional 2,881 shares in the last quarter. 88.43% of the stock is currently owned by institutional investors and hedge funds.

Align Technology Price Performance

NASDAQ:ALGN opened at $131.82 on Wednesday. Align Technology, Inc. has a fifty-two week low of $127.70 and a fifty-two week high of $262.87. The stock has a market capitalization of $9.56 billion, a PE ratio of 22.23, a price-to-earnings-growth ratio of 1.48 and a beta of 1.65. The business’s 50-day simple moving average is $158.09 and its 200-day simple moving average is $169.27.

Align Technology (NASDAQ:ALGN) last released its quarterly earnings data on Wednesday, July 30th. The medical equipment provider reported $2.49 earnings per share for the quarter, missing the consensus estimate of $2.57 by ($0.08). Align Technology had a net margin of 11.04% and a return on equity of 13.36%. The business had revenue of $1.01 billion for the quarter, compared to the consensus estimate of $1.06 billion. During the same quarter last year, the firm earned $2.41 EPS. The company’s revenue for the quarter was down 1.6% on a year-over-year basis. Align Technology has set its Q3 2025 guidance at EPS. On average, research analysts expect that Align Technology, Inc. will post 7.98 earnings per share for the current year.

Align Technology declared that its board has authorized a share repurchase program on Tuesday, August 5th that allows the company to buyback $200.00 million in outstanding shares. This buyback authorization allows the medical equipment provider to repurchase up to 2% of its shares through open market purchases. Shares buyback programs are generally a sign that the company’s management believes its shares are undervalued.

Wall Street Analysts Forecast Growth

Several research firms have issued reports on ALGN. Zacks Research lowered Align Technology from a “hold” rating to a “strong sell” rating in a research note on Monday, September 1st. Stifel Nicolaus decreased their target price on Align Technology from $275.00 to $200.00 and set a “buy” rating on the stock in a report on Thursday, July 31st. Mizuho set a $210.00 target price on Align Technology in a report on Thursday, July 31st. Wells Fargo & Company decreased their target price on Align Technology from $246.00 to $199.00 and set an “overweight” rating on the stock in a report on Thursday, July 31st. Finally, Morgan Stanley restated an “equal weight” rating and set a $154.00 target price (down previously from $249.00) on shares of Align Technology in a report on Thursday, July 31st. One research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, five have issued a Hold rating and two have given a Sell rating to the company. According to MarketBeat.com, Align Technology currently has a consensus rating of “Moderate Buy” and a consensus target price of $215.00.

Insider Buying and Selling at Align Technology

In other news, CEO Joseph M. Hogan bought 7,576 shares of the business’s stock in a transaction on Friday, August 1st. The shares were purchased at an average price of $131.49 per share, for a total transaction of $996,168.24. Following the purchase, the chief executive officer owned 184,945 shares of the company’s stock, valued at approximately $24,318,418.05. The trade was a 4.27% increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.66% of the stock is owned by company insiders.

Align Technology Profile

Align Technology, Inc designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of younger patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years, which is a mixture of primary/baby and permanent teeth.